Blood pressure control for diabetic retinopathy.

Area of Science:

• Ophthalmology
• Endocrinology
• Nephrology
• Cardiology

Background:

• Diabetic retinopathy (DR) is a leading cause of vision loss in diabetic patients.
• Blood glucose control is crucial for preventing diabetes complications.
• The role of blood pressure control in preventing DR remains debated, with conflicting study results.

Purpose of the Study:

• To systematically review evidence on blood pressure control interventions in diabetics concerning DR incidence and progression.
• To assess the impact on visual acuity, adverse events, quality of life, and costs.
• To compare different classes of antihypertensive medications for these outcomes.

Main Methods:

• Conducted a systematic review of randomized controlled trials (RCTs) from electronic databases and trial registries.
• Included RCTs comparing intense vs. less intense blood pressure control, or blood pressure control vs. usual care/placebo.
• Extracted data on retinopathy, visual acuity, adverse events, quality of life, and cost-effectiveness at annual intervals.

Main Results:

• Fifteen RCTs involving over 13,000 participants (Type 1 and Type 2 diabetics) were included.
• Intensive blood pressure control showed a benefit in reducing the 4-5 year incidence of diabetic retinopathy (RR 0.80; 95% CI 0.71-0.92).
• Evidence for slowing DR progression, preventing vision loss, or reducing other adverse events was limited or not supported.

Conclusions:

• Blood pressure intervention demonstrates a beneficial effect in preventing diabetic retinopathy incidence for up to 4-5 years.
• Limited evidence exists to support blood pressure intervention for slowing DR progression or preventing other related complications.
• The overall benefit of blood pressure intervention solely for preventing diabetic retinopathy is weakened by modest evidence for incidence and lack of evidence for progression.